Abstract
A fixed-dose combination (FDC) of ertugliflozin, a selective sodium-glucose cotransporter 2 inhibitor, and immediate-release metformin is approved for......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
